Peer Exchange

  

New Paradigms: Preventive Treatment for Chronic Migraine


A panel of experts provides a historical perspective on the prevention of migraine, particularly the frequency and intensity of attacks while on therapy.

Key opinion leaders share personal approaches to decide on treatment strategies using FDA approved oral preventives for chronic migraine.

Experts share opinions on the advent of injectable monoclonal antibodies for migraine therapy & their positive outcomes in patients with comorbid conditions.

Physicians explain the mechanism of action of the OnabotulinumtoxinA with reference to migraine therapy.

Thought leaders provide insights into the benefits and risks of using hormone therapy to reduce severity of menstrual migraines.

Expert physicians emphasize the mechanism of action of antibodies and discuss their effect on the immune system during treatment of migraine.

The panel discusses how CGRPs for migraine may delay or protect against the development of cardiovascular disease due to their vasodilation effect.

Thought leaders discuss the safety and efficacy of anti-CGRP monoclonal antibodies for migraine and for which patients treatment may be successful.

Experts share experiences of miraculous responses to CGRP inhibitors in refractory patients and conversions from chronic migraines to episodic migraines.

A panel of experts discuss the cumulative benefits of using CGRP inhibitors in reducing migraine days when used over longer periods of time.

Key opinion leaders provide practical recommendations for optimizing initial non-responder experiences by using CGRP inhibitors long term.

Experts review dose, frequency, and routes of administration for erenumab, fremanezumab, galcanezumab, and eptinezumab as preventive therapy for chronic migraine.

Expert thought leaders reveal the therapeutic potential of CGRP monoclonal antibodies and antagonists in the treatment of cluster headaches.

An expert panel of physicians discuss the mechanism of action and impact of gepants and CGRP inhibition on the migraine treatment landscape.
SAP Partner Banner